TYK Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	105.04	186.83	90.76
Trading Asset Securities	53.26	6	152.73
Cash & Short-Term Investments	158.31	192.83	243.49
Cash Growth	-	-20.81%	-
Other Receivables	3.29	1.79	1.86
Receivables	3.29	1.79	1.86
Prepaid Expenses	29.76	33.2	28.22
Other Current Assets	6.98	5.88	1.17
Total Current Assets	198.34	233.71	274.73
Property, Plant & Equipment	241.24	249.85	190.2
Other Intangible Assets	65.24	68.07	73.73
Other Long-Term Assets	24.47	21.51	19.71
Total Assets	529.3	573.14	558.36
Accounts Payable	29.58	32.17	9.66
Accrued Expenses	48.72	46.94	20.7
Current Portion of Leases	23.13	22.23	23.49
Current Income Taxes Payable	0.01	0.46	2.05
Other Current Liabilities	1,228	1,199	906.33
Total Current Liabilities	1,410	1,301	962.24
Long-Term Leases	17.11	19.5	32.46
Long-Term Unearned Revenue	49.18	48.28	24.83
Other Long-Term Liabilities	95.82	84.41	39.58
Total Liabilities	1,572	1,453	1,059
Common Stock	322.96	307.36	287.99
Additional Paid-In Capital	802.74	768.34	602.71
Retained Earnings	-1,228	-1,009	-626.67
Comprehensive Income & Other	-944.05	-951.08	-769.97
Total Common Equity	-1,046	-884.48	-505.94
Minority Interest	3.97	4.45	5.19
Shareholders' Equity	-1,043	-880.03	-500.75
Total Liabilities & Equity	529.3	573.14	558.36
Total Debt	120.72	41.73	55.95
Net Cash (Debt)	37.59	151.1	187.54
Net Cash Growth	-	-19.43%	-
Net Cash Per Share	0.12	0.52	0.68
Filing Date Shares Outstanding	370.84	307.36	277.82
Total Common Shares Outstanding	370.84	307.36	277.82
Working Capital	-1,211	-1,067	-687.51
Book Value Per Share	-2.82	-2.88	-1.82
Tangible Book Value	-1,112	-952.55	-579.67
Tangible Book Value Per Share	-3.00	-3.10	-2.09
Machinery	-	18.63	17.03
Construction In Progress	-	139.17	65
Leasehold Improvements	-	15.38	8.87

Source: S&P Capital IQ. Standard template. Financial Sources.